LTC Clinical Review 

Today's Long-Term Care News

Sign up for Enews

Annals of Long-Term Care news, current issue articles, and continuing educational events can be sent directly to your email. Published monthly, you can keep up to date on everything Annals of Long-Term Care has to offer. It's free and you can unsubscribe anytime.

To begin, enter your email address below.

This Month's CME Article in Clinical Geriatrics

Gait in Older Adults: A Review of the Literature with an Emphasis Toward Achieving Favorable Clinical Outcomes, Part II
Meredith H. Harris, PT, DPT, EdD, Maureen K. Holden, PT, PhD, Lawrence P. Cahalin, PT, MA, Diane Fitzpatrick, PT, DPT, MS, Susan Lowe, PT, DPT, MS, GCS, and Paul K. Canavan, PT, PhD

Changes in motor skills that occur with aging vary widely. It is generally accepted that many bodily functions decline with age, including the ability to walk. For older individuals, walking is one of the most important factors in maintaining an independent lifestyle and remaining in the community. As aging occurs, there can be distinct changes in gait patterns. There is some controversy in the field as to whether change occurs as a result of aging or as a result of pathology.

Read Article


Feature Article

431
Annals of Long-Term Care - ISSN: 1524-7929 - Volume 13 - Issue 5-May-2005 - May 2005
Linda Hiddemen Barondess Executive Vice-President
Fred M. Feinsod, MD, MPH, CMD, and Cathy Wagner, RN, MSN, MBA

Futility at the Bedside: Futile Care versus Worth a Try
Renate G. Justin, MD
Zachary J. Palace, MD
A Policy Statement from the American Geriatrics Society (AGS) and the Association of Directors of Geriatric Academic Programs (ADGAP)

Pharmacologic Options for Managing Psychosis in Parkinson’s Disease
David M. Roane, MD, and Dickson Jean, MD
Psychosis develops in as many as 40% of patients with Parkinson’s disease who are treated with dopaminergic agents. In the past, options to treat psychosis were limited to reducing the dose of Parkinson’s medication or adding antipsychotic medications associated with extrapyramidal side effects. Both of these approaches increased motor disability. Research and accumulating clinical experience indicate that the newer atypical antipsychotics provide a safe and effective way to manage psychosis in this patient population. For patients with combined parkinsonism and dementia, cholinesterase inhibitors may provide another option for treating psychosis. (Annals of Long-Term Care: Clinical Care and Aging 2005;13[5]:42-45)
M. Nelia Davis, MSN, APRN, CS, Sarah Toombs Smith, PhD, and Susan Tyler, APRN, BC, MSN
Your HeartECPNlime